27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis
Sigurgeirsson B, Schäkel K, Hong C-H, Effendy I, Placek W, Rich P, Bruin G, Charef P, Fu R, Hampele I, Patekar M (2021)
Journal of the American Academy of Dermatology 85(3 (Suppl.): AB150.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Sigurgeirsson, Bardur;
Schäkel, Knut;
Hong, Chih-Ho;
Effendy, IsaakUniBi 
;
Placek, Waldemar;
Rich, Phoebe;
Bruin, Gerard;
Charef, Pascal;
Fu, Rong;
Hampele, Isabelle;
Patekar, Manmath
;
Placek, Waldemar;
Rich, Phoebe;
Bruin, Gerard;
Charef, Pascal;
Fu, Rong;
Hampele, Isabelle;
Patekar, ManmathErscheinungsjahr
2021
Zeitschriftentitel
Journal of the American Academy of Dermatology
Band
85
Ausgabe
3 (Suppl.)
Art.-Nr.
AB150
ISSN
0190-9622
Page URI
https://pub.uni-bielefeld.de/record/2969496
Zitieren
Sigurgeirsson B, Schäkel K, Hong C-H, et al. 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 2021;85(3 (Suppl.): AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C. - H., Effendy, I., Placek, W., Rich, P., Bruin, G., et al. (2021). 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 85(3 (Suppl.), AB150. https://doi.org/10.1016/j.jaad.2021.06.614
Sigurgeirsson, Bardur, Schäkel, Knut, Hong, Chih-Ho, Effendy, Isaak, Placek, Waldemar, Rich, Phoebe, Bruin, Gerard, et al. 2021. “27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”. Journal of the American Academy of Dermatology 85 (3 (Suppl.): AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C. - H., Effendy, I., Placek, W., Rich, P., Bruin, G., Charef, P., Fu, R., Hampele, I., et al. (2021). 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology 85:AB150.
Sigurgeirsson, B., et al., 2021. 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology, 85(3 (Suppl.): AB150.
B. Sigurgeirsson, et al., “27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”, Journal of the American Academy of Dermatology, vol. 85, 2021, : AB150.
Sigurgeirsson, B., Schäkel, K., Hong, C.-H., Effendy, I., Placek, W., Rich, P., Bruin, G., Charef, P., Fu, R., Hampele, I., Patekar, M.: 27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis. Journal of the American Academy of Dermatology. 85, : AB150 (2021).
Sigurgeirsson, Bardur, Schäkel, Knut, Hong, Chih-Ho, Effendy, Isaak, Placek, Waldemar, Rich, Phoebe, Bruin, Gerard, Charef, Pascal, Fu, Rong, Hampele, Isabelle, and Patekar, Manmath. “27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis”. Journal of the American Academy of Dermatology 85.3 (Suppl.) (2021): AB150.
Google Scholar